Bridgeway Capital Management, LLC Age X Therapeutics, Inc. Transaction History

Bridgeway Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.45 - $0.89 $11,250 - $22,250	-25,000 Reduced 14.73%	144,770 $128,000
Q3 2021 Nov 15, 2021	SELL	$0.93 - $1.54 $69,750 - $115,500	-75,000 Reduced 30.64%	169,770 $160,000
Q2 2021 Aug 16, 2021	SELL	$1.14 - $1.77 $68,400 - $106,200	-60,000 Reduced 19.69%	244,770 $379,000
Q1 2021 May 17, 2021	BUY	$1.56 - $2.7 $156,000 - $270,000	100,000 Added 48.84%	304,770 $494,000
Q3 2020 Nov 16, 2020	BUY	$0.79 - $1.52 $39,500 - $76,000	50,000 Added 32.31%	204,770 $166,000
Q2 2020 Aug 14, 2020	BUY	$0.68 - $1.13 $105,243 - $174,890	154,770 New	154,770 $147,000
Q1 2020 May 15, 2020	SELL	$0.78 - $1.95 $18,773 - $46,934	-24,069 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$3.0 - $4.85 $3 - $4	-1 Reduced -0.0%	24,069 $97,000
Q4 2018 Feb 14, 2019	BUY	$2.49 - $5.5 $59,934 - $132,385	24,070 New	24,070 $72,000

Ticker AGE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,945,100
Description
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-rel...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.